Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20121
20174
20191
20201
20212
20235
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed6
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Revolution Medicines, Inc.2
Assistance Publique - Hôpitaux de Paris1
BBB-Therapeutics B.V.1
Bristol-Myers Squibb1
Centocor, Inc.1
Centre Hospitalier Universitaire de Besancon1
Grey Wolf Therapeutics1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms19
Carcinoma, Non-Small-Cell Lung12
Neoplasms9
Head and Neck Neoplasms8
Colorectal Neoplasms7
Neoplasms by Site7
Breast Neoplasms5
Bronchial Neoplasms5
Colonic Neoplasms5
Lung Diseases5

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.